<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id><journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id><journal-id journal-id-type="publisher-id">MGG3</journal-id><journal-title-group><journal-title>Molecular Genetics &#x00026; Genomic Medicine</journal-title></journal-title-group><issn pub-type="epub">2324-9269</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5702561</article-id><article-id pub-id-type="doi">10.1002/mgg3.337</article-id><article-id pub-id-type="publisher-id">MGG3337</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Spectrum of <styled-content style="fixed-case">CFTR</styled-content> gene mutations in Ecuadorian cystic fibrosis patients: the second report of the p.H609R mutation</article-title><alt-title alt-title-type="left-running-head">S. C. Ortiz <italic>et&#x000a0;al</italic>.</alt-title></title-group><contrib-group><contrib id="mgg3337-cr-0001" contrib-type="author" corresp="yes"><name><surname>Ortiz</surname><given-names>Sof&#x000ed;a C.</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6575-9577</contrib-id><address><email>sofia.ortiz@netlab.com.ec</email></address><xref ref-type="aff" rid="mgg3337-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="mgg3337-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="mgg3337-cr-0002" contrib-type="author" corresp="yes"><name><surname>Aguirre</surname><given-names>Santiago J.</given-names></name><address><email>santiago.aguirre@netlab.com.ec</email></address><xref ref-type="aff" rid="mgg3337-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3337-cr-0003" contrib-type="author"><name><surname>Flores</surname><given-names>Sof&#x000ed;a</given-names></name><xref ref-type="aff" rid="mgg3337-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3337-cr-0004" contrib-type="author"><name><surname>Maldonado</surname><given-names>Claudio</given-names></name><xref ref-type="aff" rid="mgg3337-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3337-cr-0005" contrib-type="author"><name><surname>Mej&#x000ed;a</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="mgg3337-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3337-cr-0006" contrib-type="author"><name><surname>Salinas</surname><given-names>Lilian</given-names></name><xref ref-type="aff" rid="mgg3337-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="mgg3337-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">&#x000c1;rea de Biolog&#x000ed;a Molecular</named-content>
<institution>NETLAB Laboratorios Especializados</institution>
<named-content content-type="city">Quito</named-content>
<country country="EC">Ecuador</country>
</aff><aff id="mgg3337-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Departamento de Ciencias de la Vida y la Agricultura</named-content>
<named-content content-type="organisation-division">Grupo de Investigaci&#x000f3;n en Sanidad Animal y Humana</named-content>
<institution>Universidad de las Fuerzas Armadas ESPE</institution>
<named-content content-type="city">Sangolqui</named-content>
<country country="EC">Ecuador</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Sof&#x000ed;a C. Ortiz, Calle &#x0201c;A&#x0201d; (Oe7A) N31&#x02010;145 y Av. Mariana de Jes&#x000fa;s, Quito, Ecuador. Tel: +593983249582; Fax: 5932920911; E&#x02010;mail: <email>sofia.ortiz@netlab.com.ec</email><break/>
and<break/>
Santiago J. Aguirre, Calle &#x0201c;A&#x0201d; (Oe7A) N31&#x02010;145 y Av. Mariana de Jes&#x000fa;s, Quito, Ecuador. Tel: +593991383443; Fax: 5932920911; E&#x02010;mail: <email>santiago.aguirre@netlab.com.ec</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2017</year></pub-date><volume>5</volume><issue>6</issue><issue-id pub-id-type="doi">10.1002/mgg3.2017.5.issue-6</issue-id><fpage>751</fpage><lpage>757</lpage><history><date date-type="received"><day>07</day><month>4</month><year>2017</year></date><date date-type="rev-recd"><day>31</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>12</day><month>8</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 Wiley Periodicals, Inc. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 NETLAB Laboratorios Especializados. <italic>Molecular Genetics &#x00026; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:MGG3-5-751.pdf"/><abstract id="mgg3337-abs-0001"><title>Abstract</title><sec id="mgg3337-sec-0001"><title>Background</title><p>High heterogeneity in the <styled-content style="fixed-case">CFTR</styled-content> gene mutations disturbs the molecular diagnosis of cystic fibrosis (<styled-content style="fixed-case">CF</styled-content>). In order to improve the diagnosis of <styled-content style="fixed-case">CF</styled-content> in our country, the present study aims to define a panel of common <styled-content style="fixed-case">CFTR</styled-content> gene mutations by sequencing 27 exons of the gene in Ecuadorian Cystic Fibrosis patients.</p></sec><sec id="mgg3337-sec-0002"><title>Methods</title><p>Forty&#x02010;eight Ecuadorian individuals with suspected/confirmed <styled-content style="fixed-case">CF</styled-content> diagnosis were included. Twenty&#x02010;seven exons of <styled-content style="fixed-case">CFTR</styled-content> gene were sequenced to find sequence variations. Prevalence of pathogenic variations were determined and compared with other countries&#x02019; data.</p></sec><sec id="mgg3337-sec-0003"><title>Results</title><p>We found 70 sequence variations. Eight of these are <styled-content style="fixed-case">CF</styled-content>&#x02010;causing mutations: p.F508del, p.G85E, p.G330E, p.A455E, p.G970S, W1098X, R1162X, and N1303K. Also this study is the second report of p.H609R in Ecuadorian population. Mutation prevalence differences between Ecuadorian population and other Latin America countries were found.</p></sec><sec id="mgg3337-sec-0004"><title>Conclusion</title><p>The panel of mutations suggested as an initial screening for the Ecuadorian population with cystic fibrosis should contain the mutations: p.F508del, p.G85E, p.G330E, p.A455E, p.G970S, W1098X, R1162X, and N1303K.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mgg3337-kwd-0001"><styled-content style="fixed-case">CFTR</styled-content> gene</kwd><kwd id="mgg3337-kwd-0002">cystic fibrosis</kwd><kwd id="mgg3337-kwd-0003">heterogeneity</kwd><kwd id="mgg3337-kwd-0004">molecular diagnosis</kwd><kwd id="mgg3337-kwd-0005">mutation</kwd><kwd id="mgg3337-kwd-0006">polymorphism</kwd></kwd-group><funding-group><award-group><funding-source>NETLAB</funding-source></award-group></funding-group><counts><fig-count count="0"/><table-count count="6"/><page-count count="7"/><word-count count="4757"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>mgg3337</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>November 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.6.1 mode:remove_FC converted:26.11.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="mgg3337-cit-1001">
<source>Molecular Genetics &#x00026; Genomic Medicine</source>
<year>2017</year>; <volume>5</volume>(<issue>6</issue>): <fpage>751</fpage>&#x02013;<lpage>757</lpage>
</mixed-citation>
</p></notes></front><body><sec id="mgg3337-sec-0005"><title>Introduction</title><p>Cystic fibrosis (CF), an autosomal recessive disease caused by mutations in the CFTR (OMIM: 602421) gene is a multisystem impairment that involves lung damage, exocrine pancreatic insufficiency, liver disease, intestinal motility disorder, and high concentrations of sweat chlorides (Kan et&#x000a0;al. <xref rid="mgg3337-bib-0011" ref-type="ref">2015</xref>).</p><p>More than 1900 sequence variations in CFTR gene (OMIM:602421) have been reported (Derichs <xref rid="mgg3337-bib-0007" ref-type="ref">2013</xref>). These variations and their prevalence vary in populations based on their geographic and ethnic origins (Hakkak et&#x000a0;al. <xref rid="mgg3337-bib-0009" ref-type="ref">2013</xref>). High heterogeneity in CFTR gene (OMIM:602421) mutations spectrum in Latin America (Orozco et&#x000a0;al. <xref rid="mgg3337-bib-0018" ref-type="ref">2000</xref>) disturbs the molecular diagnosis of cystic fibrosis in this region (Luna et&#x000a0;al. <xref rid="mgg3337-bib-0014" ref-type="ref">2007</xref>).</p><p>The incidence of cystic fibrosis in Ecuador is 1:11.252 born alive, and CFTR gene (OMIM: 602421) mutations in Ecuadorian CF patients using a kit of common mutations worldwide are: p.F508del, p.G85E, p.G542X, p.N1303K, p.G551D, and p.R334W (Valle et&#x000a0;al. <xref rid="mgg3337-bib-0021" ref-type="ref">2007</xref>). Moya et&#x000a0;al. (<xref rid="mgg3337-bib-0017" ref-type="ref">2009</xref>) reported p.H609R mutation in Ecuadorian population for first time.</p><p>Ecuador has not established a common CFTR mutations panel for the diagnosis of cystic fibrosis, therefore this study aims to define this panel by sequencing the 27 exons of this gene in Ecuadorian cystic fibrosis patients.</p></sec><sec id="mgg3337-sec-0006"><title>Materials and Methods</title><sec id="mgg3337-sec-0007"><title>Ethical compliance</title><p>This study was approved by the Hospital Eugenio Espejo Bioethics &#x02032;committee.</p></sec><sec id="mgg3337-sec-0008"><title>Methodology</title><p>Forty&#x02010;eight Ecuadorian individuals with suspected/confirmed CF diagnosis from &#x0201c;Fundaci&#x000f3;n Ecuatoriana de Fibrosis Qu&#x000ed;stica&#x0201d; were included in this study. They and their legal representatives signed an informed consent for this study. The following procedures were performed at &#x0201c;NETLAB Laboratorios Especializados&#x0201d;.</p><p>In brief, genomic DNA was extracted from the individuals&#x02032; peripheral blood lymphocytes with QIAcube (Qiagen, Valencia, CA, USA). For each sample, 27 exons of CFTR gene (OMIM:602421) were amplified by PCR using the Platinum Taq DNA Polymerase (Invitrogen, Carlsbad, CA, USA) and the primers designed by Montgomery et&#x000a0;al. (<xref rid="mgg3337-bib-0015" ref-type="ref">2007</xref>) in the GeneAmp PCR System 9700 (Applied Biosystems, Foster City, CA, USA).</p><p>Agarose gel electrophoresis was run to verify amplicons sizes matched with the given by Montgomery et&#x000a0;al. (<xref rid="mgg3337-bib-0015" ref-type="ref">2007</xref>) for CFTR gene (OMIM:602421) exons. Then the amplicons were purified by precipitation with ethanol/sodium acetate protocol (Francis <xref rid="mgg3337-bib-0008" ref-type="ref">2005</xref>).</p><p>Sequencing was performed with the Big Dye Terminator Cycle Sequencing Kit (Applied Biosystems), and the sequencing products were purified by precipitation with Etanol/EDTA protocol suggested by the Big Dye Terminator Cycle Sequencing Kit Manual.</p><p>Capillary electrophoresis was carried out in the 3500 Genetic Analyzer (Applied Biosystems). The sequences were analyzed on SeqScape 3 Software to compare them with CFTR gene (OMIM: 602421) exon sequences at NCBI database, and to find sequence variations (Table&#x000a0;<xref rid="mgg3337-tbl-0001" ref-type="table-wrap">1</xref>).</p><table-wrap id="mgg3337-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Reference sequences of the 27 exons of CFTR (OMIM: 602421) gene</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Exon</th><th align="left" valign="top" rowspan="1" colspan="1">GenBank reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">M55106.1</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">M55107.1</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">M55108.1</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">M55109.1</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">M55110.1</td></tr><tr><td align="left" rowspan="1" colspan="1">6a</td><td align="left" rowspan="1" colspan="1">M55111.1</td></tr><tr><td align="left" rowspan="1" colspan="1">6b</td><td align="left" rowspan="1" colspan="1">M55111.1</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">M55112.1</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">M55113.1</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">M55114.1</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">M55115.1</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">M55116.1</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">M55117.1</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">M55118.1</td></tr><tr><td align="left" rowspan="1" colspan="1">14a</td><td align="left" rowspan="1" colspan="1">M55119.1</td></tr><tr><td align="left" rowspan="1" colspan="1">14b</td><td align="left" rowspan="1" colspan="1">M55120.1</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">M55121.1</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">M55122.1</td></tr><tr><td align="left" rowspan="1" colspan="1">17a</td><td align="left" rowspan="1" colspan="1">M55123.1</td></tr><tr><td align="left" rowspan="1" colspan="1">17b</td><td align="left" rowspan="1" colspan="1">M55124.1</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">M55125.1</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">M55126.1</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">M55127.1</td></tr><tr><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">M55128.1</td></tr><tr><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">M55129.1</td></tr><tr><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">M55130.1</td></tr><tr><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">M55131.1</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec></sec><sec id="mgg3337-sec-0009"><title>Results</title><sec id="mgg3337-sec-0010"><title>Sequence variations</title><p>We found 70 sequence variations in the 27 exons of the CFTR gene (OMIM: 602421) (Table&#x000a0;<xref rid="mgg3337-tbl-0002" ref-type="table-wrap">2</xref>) Eight of these are CF&#x02010;causing mutations: p.F508del, p.G85E, p.G330E, p.A455E, p.G970S, W1098X, R1162X, and N1303K. The p.H609R mutation was identified in 10 patients. It has been reported as probably pathogenic in one study in the Ecuadorian population by Moya et&#x000a0;al. (<xref rid="mgg3337-bib-0017" ref-type="ref">2009</xref>).</p><table-wrap id="mgg3337-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Sequence variations in this study for the 27 exons of the CFTR (602421) gene</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Exon</th><th align="left" valign="top" rowspan="1" colspan="1">Sequence variation</th><th align="left" valign="top" rowspan="1" colspan="1">Type of variation (NCBI)</th><th align="left" valign="top" rowspan="1" colspan="1">Amino acid change (NCBI)</th><th align="left" valign="top" rowspan="1" colspan="1">Clinical significance</th><th align="left" valign="top" rowspan="1" colspan="1">Number of patients</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">1</td><td align="left" rowspan="1" colspan="1">g.19395G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Not assigned</td><td align="left" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">g.19396A&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.19304delG</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.19304G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Benign allele<xref ref-type="fn" rid="mgg3337-note-0007">d</xref>
</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="13" colspan="1">2</td><td align="left" rowspan="1" colspan="1">g.43590T&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43510_43511delTG</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43473delG</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43621T&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43580G&#x0003e;T</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43594A&#x0003e;G</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43583A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43575G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43582T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Untested allele<xref ref-type="fn" rid="mgg3337-note-0008">e</xref>
</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43598G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43592T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Untested allele<xref ref-type="fn" rid="mgg3337-note-0008">e</xref>
</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43555G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">g.43544T&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">g.48340G&#x0003e;A</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Missense</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">p.G85E</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Pathogenic</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">g.70182A&#x0003e;T</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">p.K114Ter</td><td align="left" rowspan="1" colspan="1">Benign<xref ref-type="fn" rid="mgg3337-note-0009">f</xref> (score:0.000)</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="4" colspan="1">6a</td><td align="left" rowspan="1" colspan="1">g.74655delA</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.74534G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">g.74491G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.74630T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="4" colspan="1">6b</td><td align="left" rowspan="1" colspan="1">g.75901C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Benign allele</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">g.75923T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">g.75886A&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.75896T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="2" colspan="1">7</td><td align="left" rowspan="1" colspan="1">g.79447C&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">g.79434delA</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">frameshift</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">p.G330E</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Pathogenic</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="2" colspan="1">9</td><td align="left" rowspan="1" colspan="1">g.88121G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">g.88012C&#x0003e;T</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Missense</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">p.A455E</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Pathogenic</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="2" colspan="1">10</td><td align="left" rowspan="1" colspan="1">g.98696A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1">p.M470V<xref ref-type="fn" rid="mgg3337-note-0004">a</xref>
</td><td align="left" rowspan="1" colspan="1">Polymorphism</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">g.98808_98811delTCT</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">cds&#x02010;indel</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">p.F508del</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Pathogenic</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="7" colspan="1">13</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">g.131210A&#x0003e;G</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Missense</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">p.H609R<xref ref-type="fn" rid="mgg3337-note-0006">c</xref>
</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Probably damaging<xref ref-type="fn" rid="mgg3337-note-0009">f</xref> (score: 0.9999)</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">g.131478G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.131437C&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.131851G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">g.131797C&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.131653A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.131911G&#x0003e;T</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="3" colspan="1">14a</td><td align="left" rowspan="1" colspan="1">g.134218T&#x0003e;G</td><td align="left" rowspan="1" colspan="1">cds&#x02010;synom</td><td align="left" rowspan="1" colspan="1">p.T854T<xref ref-type="fn" rid="mgg3337-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">Polymorphism</td><td align="left" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">g.134337T&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.134228G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="2" colspan="1">14b</td><td align="left" rowspan="1" colspan="1">g.142153T&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.142152T&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="4" colspan="1">15</td><td align="left" rowspan="1" colspan="1">g.142989G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">cds&#x02010;synom</td><td align="left" rowspan="1" colspan="1">p.T966T<xref ref-type="fn" rid="mgg3337-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">Polymorphism</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.143018G&#x0003e;T</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.142999&#x000a0;G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1">p.G970S</td><td align="left" rowspan="1" colspan="1">Pathogenic</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">g.142934T&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">17a</td><td align="left" rowspan="1" colspan="1">g.14998T&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="3" colspan="1">17b</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">g.15095&#x000a0;G&#x0003e;A</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Stop&#x02010;gain</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">p.W1098X</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Pathogenic</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">g.151025G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.151010delT</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="6" colspan="1">19</td><td align="left" rowspan="1" colspan="1">g.166821G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">g.166824C&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.166921A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">g.166880T&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">g.166799A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1">p.K1177R</td><td align="left" rowspan="1" colspan="1">Benign<xref ref-type="fn" rid="mgg3337-note-0009">f</xref> (Score:0.000)</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">g.166754C&#x0003e;T</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Stop&#x02010;gain</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">p.R1162X</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Pathogenic</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="2" colspan="1">20</td><td align="left" rowspan="1" colspan="1">g.181807A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">cds&#x02010;synom</td><td align="left" rowspan="1" colspan="1">p.P1290P<xref ref-type="fn" rid="mgg3337-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">Polymorphism</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">g.181837 A&#x0003e;G</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">21</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">g.192094C&#x0003e;G</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Missense</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">p.N1303K</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">Pathogenic</td><td align="left" style="bgcolor:#DC143C" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="2" colspan="1">22</td><td align="left" rowspan="1" colspan="1">g.204099A&#x0003e;C</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">34</td></tr><tr><td align="left" rowspan="1" colspan="1">g.203927A&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="2" colspan="1">23</td><td align="left" rowspan="1" colspan="1">g.204760G&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">g.204768A&#x0003e;G</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="3" colspan="1">24</td><td align="left" rowspan="1" colspan="1">g.206271&#x000a0;G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">cds&#x02010;synom</td><td align="left" rowspan="1" colspan="1">p.Q1463Q<xref ref-type="fn" rid="mgg3337-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">Polymorphism</td><td align="left" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">g.206360C&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unreported</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">g.206154C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">cds&#x02010;synom</td><td align="left" rowspan="1" colspan="1">p.Y1424Y<xref ref-type="fn" rid="mgg3337-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">Polymorphism</td><td align="left" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="mgg3337-note-0003"><p>GenBank Reference sequence for the CFTR (OMIM: 602421) gene: NG_016465.4.</p></fn><fn id="mgg3337-note-0004"><label>a</label><p>Polymorphism (Huang et&#x000a0;al.2008).</p></fn><fn id="mgg3337-note-0005"><label>b</label><p>Polymorphism or neutral variant (Trujillano, et&#x000a0;al., <xref rid="mgg3337-bib-0020" ref-type="ref">2015</xref>).</p></fn><fn id="mgg3337-note-0006"><label>c</label><p>H609R (Moya et&#x000a0;al. <xref rid="mgg3337-bib-0017" ref-type="ref">2009</xref>).</p></fn><fn id="mgg3337-note-0007"><label>d</label><p>Benign nonpathogenic allele.</p></fn><fn id="mgg3337-note-0008"><label>e</label><p>Cases where data are not available or are unknown.</p></fn><fn id="mgg3337-note-0009"><label>f</label><p>Predicted with polyphen&#x02010;2.</p></fn><fn id="mgg3337-note-0100"><p>Mutations with red shadow have been reported as pathogenic.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="mgg3337-sec-0011"><title>Mutation frequencies and prevalence</title><p>The diagnosis of cystic fibrosis is established when individuals have one or more phenotypic characteristics of the disease, and evidence of abnormality in the function of the CFTR by the presence of allelic variants pathogenic CFTR (OMIM: OMIM:602421) or two values of chloride the abnormal sweat (Moskowitz et&#x000a0;al. <xref rid="mgg3337-bib-0016" ref-type="ref">2008</xref>).</p><p>According to that criteria, from the 48 individuals we took the 30 patients with pathogenic mutations, and seven patients with clinical diagnosis confirmed but with unknown clinical significance mutation (Table&#x000a0;<xref rid="mgg3337-tbl-0004" ref-type="table-wrap">4</xref>) in order to obtain mutation frequencies, so <italic>n</italic>&#x000a0;=&#x000a0;37.</p><p>p.H609R mutation was included in pathogenic mutations because it has been reported in four Ecuadorian patients with clinical diagnosis of cystic fibrosis by Moya et&#x000a0;al. (<xref rid="mgg3337-bib-0017" ref-type="ref">2009</xref>), and in our study, p.H609R was found in homozygous state in four patients with cystic fibrosis symptoms. These symptoms match with the diagnostic criteria for cystic fibrosis suggested by the World Health Organization, (<xref rid="mgg3337-bib-0022" ref-type="ref">2006</xref>), so p.H609R probably is a CF mutation (Table&#x000a0;<xref rid="mgg3337-tbl-0003" ref-type="table-wrap">3</xref>). Also, the software polyphen&#x02010;2 gives a score of approximately 1.00 to the&#x000a0;p.H609R as a probably damaging mutation.</p><table-wrap id="mgg3337-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Clinical data of homozygous patients for the p.H609R</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Patient no</th><th align="left" valign="top" rowspan="1" colspan="1">Age</th><th align="left" valign="top" rowspan="1" colspan="1">Sweat test I</th><th align="left" valign="top" rowspan="1" colspan="1">Sweat test II</th><th align="left" valign="top" rowspan="1" colspan="1">Clinic</th><th align="left" valign="top" rowspan="1" colspan="1">Diagnostic and clinical suspicion criteria according to age group. (World Health Organization)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">H</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">119</td><td align="left" rowspan="1" colspan="1">No data</td><td align="left" rowspan="1" colspan="1">Chronic sinusitis and colonization by <italic>Pseudomonas aeruginosa</italic>
</td><td align="left" rowspan="2" colspan="1">Children: 
<list list-type="bullet" id="mgg3337-list-0001"><list-item><p>Unexplained chronic respiratory symptoms</p></list-item><list-item><p>
<italic>Pseudomonas aeruginosa</italic> in bronchial secretions</p></list-item><list-item><p>Chronic sinusitis</p></list-item><list-item><p>Nasal polyposis</p></list-item><list-item><p>Bronchiectasis</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">No data</td><td align="left" rowspan="1" colspan="1">No data</td><td align="left" rowspan="1" colspan="1">Lung problems</td></tr><tr><td align="left" rowspan="1" colspan="1">J</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">115</td><td align="left" rowspan="1" colspan="1">131</td><td align="left" rowspan="1" colspan="1">Mild lung problems and pancreatic problems. Hospitalized for pancreatitis.</td><td align="left" rowspan="2" colspan="1">Teenagers and Adults: 
<list list-type="bullet" id="mgg3337-list-0002"><list-item><p>Chronic and suppurative unexplained lung disease and</p></list-item><list-item><p>Recurrent abdominal pain</p></list-item><list-item><p>Pancreatitis</p></list-item><list-item><p>Distal intestinal obstruction syndrome</p></list-item><list-item><p>Liver cirrhosis and portal hypertension</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">K</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">134</td><td align="left" rowspan="1" colspan="1">No data</td><td align="left" rowspan="1" colspan="1">Bronchiectasis. Frequently hospitalized for lung and digestive exacerbations</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="mgg3337-tbl-0004" xml:lang="en" orientation="portrait" position="float"><label>Table 4</label><caption><p>Variations without clinical significance in seven patients with twice positive for the sweat test</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Patient</th><th align="left" valign="top" rowspan="1" colspan="1">Sweat test I</th><th align="left" valign="top" rowspan="1" colspan="1">Sweat test II</th><th align="left" valign="top" rowspan="1" colspan="1">Mutations</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">A</td><td align="left" rowspan="2" colspan="1">118</td><td align="left" rowspan="2" colspan="1">98</td><td align="left" rowspan="1" colspan="1">g.19395G&#x0003e;A Homozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.74655del A Homozygous</td></tr><tr><td align="left" rowspan="5" colspan="1">B</td><td align="left" rowspan="5" colspan="1">75</td><td align="left" rowspan="5" colspan="1">112</td><td align="left" rowspan="1" colspan="1">c.43590T&#x0003e;G Heterozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">g.75901C&#x0003e;T Heterozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.134337T&#x0003e;C Homozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.166821G&#x0003e;C Homozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">g.206360C&#x0003e;A Homozygous</td></tr><tr><td align="left" rowspan="2" colspan="1">C</td><td align="left" rowspan="2" colspan="1">82</td><td align="left" rowspan="2" colspan="1">87</td><td align="left" rowspan="1" colspan="1">g.19395G&#x0003e;A Homozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.204099A&#x0003e;C Homozygous</td></tr><tr><td align="left" rowspan="2" colspan="1">D</td><td align="left" rowspan="2" colspan="1">76</td><td align="left" rowspan="2" colspan="1">78</td><td align="left" rowspan="1" colspan="1">c.79447C&#x0003e;A Heterozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.204099A&#x0003e;C Homozygous</td></tr><tr><td align="left" rowspan="5" colspan="1">E</td><td align="left" rowspan="5" colspan="1">88</td><td align="left" rowspan="5" colspan="1">90</td><td align="left" rowspan="1" colspan="1">g.19395G&#x0003e;A Homozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.142153T&#x0003e;G Heterozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.204099A&#x0003e;C Homozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.75923T&#x0003e;C Heterozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.75886A&#x0003e;C Heterozygous</td></tr><tr><td align="left" rowspan="3" colspan="1">F</td><td align="left" rowspan="3" colspan="1">80</td><td align="left" rowspan="3" colspan="1">89</td><td align="left" rowspan="1" colspan="1">p.M470V Heterozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.204099A&#x0003e;C Homozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">c.206360C&#x0003e;A Homozygous</td></tr><tr><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">110</td><td align="left" rowspan="1" colspan="1">89</td><td align="left" rowspan="1" colspan="1">c.206360C&#x0003e;A Homozygous</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Allele frequencies for the pathogenic mutations were calculated (Table&#x000a0;<xref rid="mgg3337-tbl-0005" ref-type="table-wrap">5</xref>). Hypothesis test that was performed to determine the mutation frequencies in this study differ significantly from other countries (Table&#x000a0;<xref rid="mgg3337-tbl-0006" ref-type="table-wrap">6</xref>).</p><table-wrap id="mgg3337-tbl-0005" xml:lang="en" orientation="portrait" position="float"><label>Table 5</label><caption><p>Frequencies for the pathogenic mutations</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Mutation</th><th align="left" valign="top" rowspan="1" colspan="1">Absolute allele frequency</th><th align="left" valign="top" rowspan="1" colspan="1">Relative allele frequency (%) prevalence</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">p.F508del</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">20.27</td></tr><tr><td align="left" rowspan="1" colspan="1">p. H609R</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">18.92</td></tr><tr><td align="left" rowspan="1" colspan="1">p. G85E</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">8.11</td></tr><tr><td align="left" rowspan="1" colspan="1">p.G970S</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">4.05</td></tr><tr><td align="left" rowspan="1" colspan="1">p.W1098X</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2.70</td></tr><tr><td align="left" rowspan="1" colspan="1">p.G330E</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2.70</td></tr><tr><td align="left" rowspan="1" colspan="1">p.A455E</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1.35</td></tr><tr><td align="left" rowspan="1" colspan="1">p.R1162X</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1.35</td></tr><tr><td align="left" rowspan="1" colspan="1">p.N1303K</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1.35</td></tr></tbody></table><table-wrap-foot><fn id="mgg3337-note-0010"><p>There were patients with two of these mutations, so the absolute allele frequency is not the number of patients. The total allele frequency was calculated with 37 patients with two chromosomes each.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="mgg3337-tbl-0006" xml:lang="en" orientation="portrait" position="float"><label>Table 6</label><caption><p>Hypothesis test for the difference in proportions of pathogenic mutations frequencies (prevalences) in Ecuador and other countries</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Mutation</th><th align="left" valign="top" rowspan="1" colspan="1">Prevalence IC (95%)</th><th align="left" valign="top" rowspan="1" colspan="1">Prevalence</th><th align="left" valign="top" rowspan="1" colspan="1">Country</th><th align="left" valign="top" rowspan="1" colspan="1">
<italic>P</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="6" colspan="1">p.F508del</td><td align="left" rowspan="6" colspan="1">20.27</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">37.1</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">Ecuador (Valle et&#x000a0;al. <xref rid="mgg3337-bib-0021" ref-type="ref">2007</xref>)</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</td></tr><tr><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">41.8</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">Colombia (Keyeux et&#x000a0;al. <xref rid="mgg3337-bib-0012" ref-type="ref">2003</xref>)</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">Peru (Silva <xref rid="mgg3337-bib-0019" ref-type="ref">2008</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">30.6</td><td align="left" rowspan="1" colspan="1">Chile (Lay et&#x000a0;al. <xref rid="mgg3337-bib-0013" ref-type="ref">2011</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">40.7</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">Mexico (Orozco et&#x000a0;al. <xref rid="mgg3337-bib-0018" ref-type="ref">2000</xref>)</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</td></tr><tr><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">52.7</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">Spain (Bobadilla et&#x000a0;al. <xref rid="mgg3337-bib-0002" ref-type="ref">2002</xref>)</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">p. H609R<xref ref-type="fn" rid="mgg3337-note-0011">a</xref>
</td><td align="left" rowspan="1" colspan="1">18.92</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="4" colspan="1">p. G85E</td><td align="left" rowspan="4" colspan="1">8.11</td><td align="left" rowspan="1" colspan="1">8.9</td><td align="left" rowspan="1" colspan="1">Ecuador (Valle et&#x000a0;al. <xref rid="mgg3337-bib-0021" ref-type="ref">2007</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">0.5</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">Chile (Lay et&#x000a0;al. <xref rid="mgg3337-bib-0013" ref-type="ref">2011</xref>)</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</td></tr><tr><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">0.5</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">Mexico (Orozco et&#x000a0;al. <xref rid="mgg3337-bib-0018" ref-type="ref">2000</xref>)</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</td></tr><tr><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">0.8</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">Spain (Bobadilla et&#x000a0;al. <xref rid="mgg3337-bib-0002" ref-type="ref">2002</xref>)</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">p.G970S<xref ref-type="fn" rid="mgg3337-note-0011">a</xref>
</td><td align="left" rowspan="1" colspan="1">4.05</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">p.W1098X</td><td align="left" rowspan="1" colspan="1">2.70</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">p.R1162X</td><td align="left" rowspan="3" colspan="1">1.35</td><td align="left" rowspan="1" colspan="1">1.1</td><td align="left" rowspan="1" colspan="1">Colombia (Keyeux et&#x000a0;al. <xref rid="mgg3337-bib-0012" ref-type="ref">2003</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">0.9</td><td align="left" rowspan="1" colspan="1">Chile (Lay et&#x000a0;al. <xref rid="mgg3337-bib-0013" ref-type="ref">2011</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">1.6</td><td align="left" rowspan="1" colspan="1">Spain (Bobadilla et&#x000a0;al. <xref rid="mgg3337-bib-0002" ref-type="ref">2002</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="4" colspan="1">p.N1303K</td><td align="left" rowspan="4" colspan="1">1.35</td><td align="left" rowspan="1" colspan="1">2.4</td><td align="left" rowspan="1" colspan="1">Ecuador (Valle et&#x000a0;al. <xref rid="mgg3337-bib-0021" ref-type="ref">2007</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">Colombia (Keyeux et&#x000a0;al. <xref rid="mgg3337-bib-0012" ref-type="ref">2003</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">2.1</td><td align="left" rowspan="1" colspan="1">Mexico (Orozco et&#x000a0;al. <xref rid="mgg3337-bib-0018" ref-type="ref">2000</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">2.5</td><td align="left" rowspan="1" colspan="1">Spain (Bobadilla et&#x000a0;al. <xref rid="mgg3337-bib-0002" ref-type="ref">2002</xref>)</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">p.G330E<xref ref-type="fn" rid="mgg3337-note-0011">a</xref>
</td><td align="left" rowspan="1" colspan="1">2.70</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">p.A455E<xref ref-type="fn" rid="mgg3337-note-0011">a</xref>
</td><td align="left" rowspan="1" colspan="1">1.35</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">8.3</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">Canada (De Braekeleer <xref rid="mgg3337-bib-0004" ref-type="ref">1997</xref>)</td><td align="left" style="bgcolor:#808080" rowspan="1" colspan="1">
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</td></tr></tbody></table><table-wrap-foot><fn id="mgg3337-note-0011"><label>a</label><p>Not found mutations in the countries: Ecuador (Valle et&#x000a0;al. <xref rid="mgg3337-bib-0021" ref-type="ref">2007</xref>), Colombia (Keyeux et&#x000a0;al. <xref rid="mgg3337-bib-0012" ref-type="ref">2003</xref>), Peru (Silva <xref rid="mgg3337-bib-0019" ref-type="ref">2008</xref>), Chile (Lay et&#x000a0;al. <xref rid="mgg3337-bib-0013" ref-type="ref">2011</xref>), Mexico (Orozco et&#x000a0;al. <xref rid="mgg3337-bib-0018" ref-type="ref">2000</xref>), Spain (Bobadilla et&#x000a0;al. <xref rid="mgg3337-bib-0002" ref-type="ref">2002</xref>).</p></fn><fn id="mgg3337-note-0101"><p>Gray color means that the frequencies in this study differ significantly from other countries (p&#x000a0;&#x0003c;&#x000a0;0.05).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec></sec><sec id="mgg3337-sec-0012"><title>Discussion</title><p>To the best of our knowledge, this is the first research at molecular level in Ecuador which analyzes the 27 exons of the CFTR gene (OMIM: 602421) to determine the prevalence of CFTR gene (OMIM: 602421) mutations in this population; therefore, it is an important contribution for the diagnosis of cystic fibrosis in our country.</p><p>The result of a previous study in cystic fibrosis Ecuadorian population using a CFTR common mutations kit (INNO&#x02010;LiPA CFTR 29+ Tn) was 50% of the patients without identified mutation (Valle et&#x000a0;al. <xref rid="mgg3337-bib-0021" ref-type="ref">2007</xref>). The sequencing method applied in our study allowed to find 70 sequence variations. Eight of these are CF&#x02010;causing mutations: p.F508del, p.G85E, p.G330E, p.A455E, p.G970S, W1098X, R1162X, and N1303K and probably p.H609R. The mutation detection rate of the methodology in this study is 81% in patients with confirmed diagnosis of CF. It has been demonstrated that CFTR gene sequencing has greater sensitivity relative to other molecular techniques such as hybridization, SSCP, DDGE (Dequeker et&#x000a0;al. <xref rid="mgg3337-bib-0006" ref-type="ref">2009</xref>).</p><p>The p.F508del is the most common mutation in cystic fibrosis patients worldwide, 66% (Collazo <xref rid="mgg3337-bib-0003" ref-type="ref">2008</xref>). In this study, a frequency of 20.27% was detected, less than Spain and Colombia<bold>.</bold> The p.G85E mutation has a worldwide prevalence of 0.2% and is more common in the Mediterranean region: Spain 1%, and Italy with 1.7% (Decaestecker et&#x000a0;al. <xref rid="mgg3337-bib-0005" ref-type="ref">2004</xref>). In this study, we found a frequency of 8.11%, different from Spain, Chile, and Mexico. The prevalence of p.G85E in Ecuador is the highest in Latin America and worldwide (Valle et&#x000a0;al. <xref rid="mgg3337-bib-0021" ref-type="ref">2007</xref>) (Table&#x000a0;<xref rid="mgg3337-tbl-0006" ref-type="table-wrap">6</xref>).</p><p>The p.W1098X mutation has not been reported in other countries in Latin America or Spain, but in Turkey, had a 0.6% (Bobadilla et&#x000a0;al. <xref rid="mgg3337-bib-0002" ref-type="ref">2002</xref>) and in Israel, 1% of frequency (World Health Organization, <xref rid="mgg3337-bib-0022" ref-type="ref">2006</xref>). Prevalence of the mutations p.N1303K and p. R1162X in this study are similar to other countries. The mutation p.A455E has been found in 8.3% of French&#x02013;Canadian population (De Braekeleer <xref rid="mgg3337-bib-0004" ref-type="ref">1997</xref>) (Table&#x000a0;<xref rid="mgg3337-tbl-0006" ref-type="table-wrap">6</xref>).</p><p>Mutation frequencies of Ecuadorian population in this study are related with the profile of CFTR gene (OMIM: 602421) mutations in a previous study (Luna et&#x000a0;al. <xref rid="mgg3337-bib-0014" ref-type="ref">2007</xref>) in Latin America, where&#x000a0;three groups according to the frequency of pathogenic mutations are showed: (i) Argentina and Uruguay, (ii) Chile, Brazil, and Colombia, and (iii) Cuba, Ecuador, and Venezuela (Luna et&#x000a0;al. <xref rid="mgg3337-bib-0014" ref-type="ref">2007</xref>). These results confirm the difference of the CFTR gene (OMIM:602421) mutation spectrum between our country and others even inside of Latin America.</p><p>One of the most important findings of this study is the detection of the p.H609R mutation, this is the second report of this mutation in Ecuadorian population. Moya et&#x000a0;al. (<xref rid="mgg3337-bib-0017" ref-type="ref">2009</xref>) found p.H609R in 4 out 6 Ecuadorian cystic fibrosis patients. These patients showed twice positive for the sweat chloride test and phenotypic characteristics of the disease.</p><p>p.H609R probably has not been included in the molecular diagnostic test for cystic fibrosis in Ecuador, because three homozygous patients for this mutation did not show any mutation in a previous panel of 89 CFTR gene (OMIM: 602421) mutations, while in one patient it was found by sequencing.</p><p>The panel of mutations suggested as an initial screening for the Ecuadorian population with cystic fibrosis should contain pathogenic mutations; eight of these are CF&#x02010;causing mutations: p.F508del, p.G85E, p.G330E, p.A455E, p.G970S, W1098X, R1162X, and N1303K found in this study.</p><p>Eleven patients were excluded for the statisticts of this study, because they had mutations that have not been reported as pathogenic. Also, they lacked of clinical confirmed cystic fibrosis. Further analysis of the clinical impact of these mutations should be determined. They have not yet been classified and the penetrance is yet unknown.</p><p>A similar study on Chilean cystic fibrosis patients concluded that sequencing of coding region and adjacent intronic segments of CFTR gene (OMIM: 602421) has a 90% detection rate, yet there are a lot of variants that have not been identified. Another factor is the certainty of the clinical diagnosis of cystic fibrosis subjected to molecular analysis. This reduces the mutation rate of this method (Lay et&#x000a0;al. <xref rid="mgg3337-bib-0013" ref-type="ref">2011</xref>).</p><p>The variations found outside the exon 1 (NG_016465.3: g.19395G&#x0003e; A) and exon 22 (c.204099A&#x0003e; C) with a rate of 15% and 48% of the study population, respectively, should continue to be evaluated to determine their effect on CFTR protein, because probably are located in intronic or regulatory regions of the CFTR gene (OMIM: 602421), as it has been described for intron 16 (Bienvenu et&#x000a0;al. <xref rid="mgg3337-bib-0001" ref-type="ref">1996</xref>) and intron 23 (Yoshimura et&#x000a0;al. <xref rid="mgg3337-bib-0023" ref-type="ref">1992</xref>), where mutations cause a change in the splicing and therefore effect on the protein.</p></sec><sec id="mgg3337-sec-0014"><title>Conflict of Interest</title><p>We declare that there is not any conflict of interest in our research.</p></sec></body><back><ack id="mgg3337-sec-0013"><title>Acknowledgments</title><p>We thank the patients from Fundaci&#x000f3;n Ecuatoriana de Fibrosis Qu&#x000ed;stica and their families for participating in this study. We also thank NETLAB Laboratorios Especializados for funding our research.</p></ack><ref-list content-type="cited-references" id="mgg3337-bibl-0001"><title>References</title><ref id="mgg3337-bib-0001"><mixed-citation publication-type="journal" id="mgg3337-cit-0001">
<string-name>
<surname>Bienvenu</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Cartault</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Lesure</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Renouil</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Beldjord</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Kaplan</surname>
</string-name>. <year>1996</year>
<article-title>A splicing mutation in intron 16 of the cystic fibrosis transmembrane conductance regulator gene, associated with severe disease, is common on Reunion Island</article-title>. <source>Hum. Hered.</source>
<volume>46</volume>:<fpage>168</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">8860012</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0002"><mixed-citation publication-type="journal" id="mgg3337-cit-0002">
<string-name>
<surname>Bobadilla</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Macek</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Fine</surname>
</string-name>, and <string-name>
<given-names>P. M.</given-names>
<surname>Farrell</surname>
</string-name>. <year>2002</year>
<article-title>Cystic fibrosis: a worldwide analysis of CFTR mutations&#x02013;correlation with incidence data and application to screening</article-title>. <source>Hum. Mutat.</source>
<volume>19</volume>:<fpage>575</fpage>&#x02013;<lpage>606</lpage>.<pub-id pub-id-type="pmid">12007216</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0003"><mixed-citation publication-type="miscellaneous" id="mgg3337-cit-0003">
<string-name>
<surname>Collazo</surname>, <given-names>T.</given-names>
</string-name>
<year>2008</year> (Mayo). <article-title>Revista Cubana de Medicina General Integral</article-title>. Available at <ext-link ext-link-type="uri" xlink:href="http://www.bvs.sld.cu/revistas/ibi/vol27_2_08/ibi04208.htm">http://www.bvs.sld.cu/revistas/ibi/vol27_2_08/ibi04208.htm</ext-link>
</mixed-citation></ref><ref id="mgg3337-bib-0004"><mixed-citation publication-type="journal" id="mgg3337-cit-0004">
<string-name>
<surname>De Braekeleer</surname>, <given-names>M. A. C.</given-names>
</string-name>. <year>1997</year>
<article-title>Genotype&#x02010;phenotype correlation in cystic fibrosis patients compound heterozygous for the A455E mutation</article-title>. <source>Hum. Genet.</source>
<volume>101</volume>:<fpage>208</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">9402971</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0005"><mixed-citation publication-type="journal" id="mgg3337-cit-0005">
<string-name>
<surname>Decaestecker</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Decaestecker</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Castellani</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Jaspersz</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Cuppensz</surname>
</string-name>, and <string-name>
<given-names>K. D.</given-names>
<surname>Boeck</surname>
</string-name>. <year>2004</year>
<article-title>Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients</article-title>. <source>Eur. Respir. J.</source>
<volume>23</volume>:<fpage>679</fpage>&#x02013;<lpage>684</lpage>.<pub-id pub-id-type="pmid">15176679</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0006"><mixed-citation publication-type="journal" id="mgg3337-cit-0006">
<string-name>
<surname>Dequeker</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Stuhrmann</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Morris</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Casals</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Castellani</surname>
</string-name>. <year>2009</year>
<article-title>Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR&#x02010;related disorders &#x02013; updated European recommendations</article-title>. <source>Eur. J. Hum. Genet.</source>
<volume>17</volume>:<fpage>51</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">18685558</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0007"><mixed-citation publication-type="journal" id="mgg3337-cit-0007">
<string-name>
<surname>Derichs</surname>, <given-names>N.</given-names>
</string-name>
<year>2013</year>
<article-title>Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis</article-title>. <source>Eur. Respir. Rev.</source>
<volume>22</volume>:<fpage>58</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">23457166</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0008"><mixed-citation publication-type="miscellaneous" id="mgg3337-cit-0008">
<string-name>
<surname>Francis</surname>, <given-names>D.</given-names>
</string-name>
<year>2005</year>
<article-title>Ohio Agricultural Research and Development Center</article-title>. Retrieved Marzo 2015, available at <ext-link ext-link-type="uri" xlink:href="http://www.oardc.ohio-state.edu/tomato/604.03/Module3/PCRproductSequencing.pdf">http://www.oardc.ohio-state.edu/tomato/604.03/Module3/PCRproductSequencing.pdf</ext-link>
</mixed-citation></ref><ref id="mgg3337-bib-0009"><mixed-citation publication-type="journal" id="mgg3337-cit-0009">
<string-name>
<surname>Hakkak</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Keramatipour</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Talebi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Brook</surname>
</string-name>, <string-name>
<given-names>J. T.</given-names>
<surname>Afshari</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Raazi</surname>
</string-name>, et&#x000a0;al. <year>2013</year>
<article-title>Analysis of CFTR gene mutations in children with cystic fibrosis, first report from North&#x02010;East of Iran</article-title>. <source>Iran. J. Basic Med. Sci.</source>
<volume>16</volume>:<fpage>918</fpage>&#x02013;<lpage>921</lpage>.</mixed-citation></ref><ref id="mgg3337-bib-0011"><mixed-citation publication-type="journal" id="mgg3337-cit-0011">
<string-name>
<surname>Kan</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Roth</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Piltcher</surname>
</string-name>, and <string-name>
<given-names>R. D.</given-names>
<surname>Oliveira</surname>
</string-name>. <year>2015</year>
<article-title>Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment</article-title>. <source>J. Bras. Pneumol.</source>
<volume>41</volume>:<fpage>65</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">25750676</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0012"><mixed-citation publication-type="journal" id="mgg3337-cit-0012">
<string-name>
<surname>Keyeux</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Rodas</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Bienvenu</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Garavito</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Vidaud</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Sanchez</surname>
</string-name>, et&#x000a0;al. <year>2003</year>
<article-title>CFTR mutations in patients from Colombia: implications for local and regional molecular diagnosis programs</article-title>. <source>Hum. Mutat.</source>
<volume>22</volume>:<fpage>259</fpage>.</mixed-citation></ref><ref id="mgg3337-bib-0013"><mixed-citation publication-type="journal" id="mgg3337-cit-0013">
<string-name>
<surname>Lay</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Puga</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Astudillo</surname>
</string-name>, and <string-name>
<given-names>G. M.</given-names>
<surname>Repetto</surname>
</string-name>. <year>2011</year>
<article-title>Cystic fibrosis in Chilean patients: analysis of 36 common CFTR gene mutations cystic fibrosis</article-title>. <source>J. Cyst. Fibros.</source>
<volume>10</volume>:<fpage>66</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">21036675</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0014"><mixed-citation publication-type="journal" id="mgg3337-cit-0014">
<string-name>
<surname>Luna</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Pivettaa</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Keyeuxb</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Perez</surname>
</string-name>. <year>2007</year>
<article-title>CFTR gene analysis in Latin American CF patients: heterogeneous origin and distribution of mutations across the continent</article-title>. <source>J. Cyst. Fibros.</source>
<volume>6</volume>:<fpage>194</fpage>&#x02013;<lpage>208</lpage>.<pub-id pub-id-type="pmid">16963320</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0015"><mixed-citation publication-type="journal" id="mgg3337-cit-0015">
<string-name>
<surname>Montgomery</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Wittwer</surname>
</string-name>, <string-name>
<given-names>J. O.</given-names>
<surname>Kent</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Zhou</surname>
</string-name>. <year>2007</year>
<article-title>Scanning the cystic fibrosis transmembrane conductance regulator gene using high&#x02010;resolution DNA melting analysis</article-title>. <source>Clin. Chem.</source>
<volume>53</volume>:<fpage>1891</fpage>&#x02013;<lpage>1898</lpage>.<pub-id pub-id-type="pmid">17890437</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0016"><mixed-citation publication-type="journal" id="mgg3337-cit-0016">
<string-name>
<surname>Moskowitz</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Chmiel</surname>
</string-name>, <string-name>
<given-names>D. L.</given-names>
<surname>Sternen</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Cheng</surname>
</string-name>, <string-name>
<given-names>R. L.</given-names>
<surname>Gibson</surname>
</string-name>, <string-name>
<given-names>S. G.</given-names>
<surname>Marshall</surname>
</string-name>, et&#x000a0;al. <year>2008</year>
<article-title>Clinical practice and genetic counseling for cystic fibrosis and CFTR&#x02010;related disorders</article-title>. <source>Genet. Med.</source>
<volume>10</volume>:<fpage>851</fpage>&#x02013;<lpage>868</lpage>.<pub-id pub-id-type="pmid">19092437</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0017"><mixed-citation publication-type="journal" id="mgg3337-cit-0017">
<string-name>
<surname>Moya</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Glover</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Mond&#x000e9;jar</surname>
</string-name>, <string-name>
<given-names>M. D.</given-names>
<surname>Pastor</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Fern&#x000e1;ndez</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>S&#x000e1;nchez</surname>
</string-name>. <year>2009</year>
<article-title>CFTR H609R mutation in Ecuadorian patients with cystic fibrosis</article-title>. <source>J. Cyst. Fibros.</source>
<volume>8</volume>:<fpage>280</fpage>&#x02013;<lpage>281</lpage>.<pub-id pub-id-type="pmid">19457724</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0018"><mixed-citation publication-type="journal" id="mgg3337-cit-0018">
<string-name>
<surname>Orozco</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Vel&#x000e1;zquez</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Zielenski</surname>
</string-name>, <string-name>
<given-names>L.&#x02010;C.</given-names>
<surname>Tsui</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Ch&#x000e1;vez</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Lezana</surname>
</string-name>, et&#x000a0;al. <year>2000</year>
<article-title>Spectrum of CFTR mutations in Mexican cystic fibrosis patients: identification of five novel mutations (W1098C, 846delT, P750L, 4160insGGGG and 297&#x02013;1G A)</article-title>. <source>Hum. Genet.</source>
<volume>106</volume>:<fpage>360</fpage>&#x02013;<lpage>365</lpage>.<pub-id pub-id-type="pmid">10798368</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0019"><mixed-citation publication-type="miscellaneous" id="mgg3337-cit-0019">
<string-name>
<surname>Silva</surname>, <given-names>C.</given-names>
</string-name>
<year>2008</year>
<article-title>Cybertesis</article-title>. Retrieved 2015, available at <ext-link ext-link-type="uri" xlink:href="http://cybertesis.unmsm.edu.pe/xmlui/bitstream/handle/cybertesis/1612/silva_ac.pdf?sequence=1">http://cybertesis.unmsm.edu.pe/xmlui/bitstream/handle/cybertesis/1612/silva_ac.pdf?sequence=1</ext-link>
</mixed-citation></ref><ref id="mgg3337-bib-0020"><mixed-citation publication-type="journal" id="mgg3337-cit-0020">
<string-name>
<surname>Trujillano</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>M. E.</given-names>
<surname>Weiss</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Koster</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Papachristo</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Werber</surname>
</string-name>, <string-name>
<given-names>K. K.</given-names>
<surname>Kandaswamy</surname>
</string-name>, et&#x000a0;al. <year>2015</year>
<article-title>Validation of a semiconductor next&#x02010;generation sequencing assay for the clinical genetic screening of CFTR</article-title>. <source>Mol. Genet. Genomic Med.</source>
<volume>3</volume>:<fpage>396</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="pmid">26436105</pub-id></mixed-citation></ref><ref id="mgg3337-bib-0021"><mixed-citation publication-type="journal" id="mgg3337-cit-0021">
<string-name>
<surname>Valle</surname>, <given-names>E. P.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Burgos</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Valle</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Egas</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Ruiz</surname>
</string-name>. <year>2007</year>
<article-title>Analysis of CFTR gene mutations and Cystic Fibrosis incidence in the Ecuatorian population</article-title>. <source>Scielo</source>
<volume>48</volume>:<fpage>91</fpage>&#x02013;<lpage>98</lpage>.</mixed-citation></ref><ref id="mgg3337-bib-0022"><mixed-citation publication-type="miscellaneous" id="mgg3337-cit-0022">
<collab collab-type="authors">World Health Organization</collab>
. <year>2006</year> Retrieved 2015, available at <ext-link ext-link-type="uri" xlink:href="http://www.who.int/genomics/publications/en/HGN_WB_04.02_report.pdf">http://www.who.int/genomics/publications/en/HGN_WB_04.02_report.pdf</ext-link>
</mixed-citation></ref><ref id="mgg3337-bib-0023"><mixed-citation publication-type="journal" id="mgg3337-cit-0023">
<string-name>
<surname>Yoshimura</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>C.&#x02010;S.</given-names>
<surname>Chu</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Crystal</surname>
</string-name>. <year>1992</year>
<article-title>Alternative splicing of Intron 23 of the human cystic fibrosis transmembrane conductance regulator gene resulting in a novel exon and transcript coding for a shortened intracytoplasmic C terminus</article-title>. <source>J. Biol. Chem.</source>
<volume>268</volume>:<fpage>686</fpage>&#x02013;<lpage>690</lpage>.</mixed-citation></ref></ref-list></back></article>